| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Ying Huang is Chief Executive Officer at LEGN. Ying Huang's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.1M at current prices.
The LEGN filings lean toward selling, a net 15,502 shares.
Ying Huang has 3 Form 4 filings on record from March 2026 to June 2026, all as Chief Executive Officer at Legend Biotech (LEGN), 2026.
The 3 reported transactions were 2 open-market sales and 1 gift.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $169K.
The largest open-market sale was 9,936 shares of LEGN at an average $8.77 on March 25, 2026, about $87K.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.